myelodysplastic syndrome

Showing NaN - NaN of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia

Active, not recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Birmingham, Alabama
  • +190 more
Jan 30, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Anchorage, Alaska
  • +506 more
Jan 28, 2023

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Scottsdale, Cleveland,

Completed
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Scottsdale, Arizona
  • +3 more
Jan 12, 2023

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

    Not yet recruiting
    • Allogeneic Stem Cell Transplant Candidate
    • +4 more
    • Cellular therapy product
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jul 1, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • SY-1425 (tamibarotene)
    • +2 more
    • Hartford, Connecticut
    • +25 more
    May 4, 2022

    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)

    Active, not recruiting
    • Anemia
    • +3 more
    • Epoetin Alfa
    • +2 more
    • Birmingham, Alabama
    • +512 more
    Mar 1, 2022

    Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

    Completed
    • Myelodysplastic Syndrome
    • Iron Overload
    • Birmingham, Alabama
    • +47 more
    Jul 21, 2021

    Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,

    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • +9 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Aug 4, 2021

    Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Boston, Massachusetts
    • +3 more
    Jun 30, 2021

    Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,

    Completed
    • Acute Myeloid Leukemia
    • +10 more
    • total marrow irradiation
    • +7 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Seidman Cancer Ce
    May 5, 2021

    Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Tampa, Cleveland (Idarubicin, Cytarabine, Lenalidomide (Revlimid®))

    Completed
    • Myelodysplastic Syndrome
    • Acute Myeloid Leukemia
    • Tampa, Florida
    • +1 more
    Dec 1, 2020

    Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

    Completed
    • Related Donors Donating PBSC to a Family Member
    • +7 more
    • Tampa, Florida
    • +11 more
    Sep 3, 2020

    Cancer Survivor, Depression, Hematopoietic and Lymphoid Cell Tumor Trial in United States (Internet-Based Intervention, Medical

    Completed
    • Cancer Survivor
    • +3 more
    • Internet-Based Intervention
    • +3 more
    • Tampa, Florida
    • +5 more
    Jul 29, 2020

    Myelodysplastic Syndrome Trial in United States (CC-11006)

    Terminated
    • Myelodysplastic Syndrome
    • Tampa, Florida
    • +6 more
    Dec 11, 2019

    Multi-center, Survival Data Collection in Subjects Previously

    Completed
    • Myelodysplastic Syndrome
      • Scottsdale, Arizona
      • +14 more
      Nov 6, 2019

      Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))

      Terminated
      • Myelodysplastic Syndrome
      • vadastuximab talirine
      • +2 more
      • Gilbert, Arizona
      • +33 more
      Jan 23, 2019

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Canada, United States (Co-ArgI-PEG modified human arginase I)

      Completed
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Co-ArgI-PEG modified human arginase I
      • Ann Arbor, Michigan
      • +9 more
      Oct 15, 2018

      Myelodysplastic Syndrome Trial in United States (pracinostat, Placebo, Azacitidine)

      Completed
      • Myelodysplastic Syndrome
      • Mobile, Alabama
      • +23 more
      Sep 11, 2018

      Myelodysplastic Syndrome, MDS Trial in United States (pracinostat, Azacitidine, Decitabine)

      Completed
      • Myelodysplastic Syndrome
      • MDS
      • Mobile, Alabama
      • +20 more
      Feb 22, 2017